Biologics

Boise, Idaho-based Burst Biologics will begin a study involving spinal fusion patients.

Huntley, Ill.-based Life Spine reported record revenue growth of 424 percent in the past fiscal year for its biologics product line.

Bone Biologics Corp. reported the addition of osteoporosis and trauma indications to its portfolio.

The global spine biologics market will grow through 2024, based on a Transparency Market Research report, according to medGadget.

Four spine surgeons discuss trends in the use of spine biologics.

  The global spine biologics market is predicted to exceed more than $2.5 billion by 2022 with a growth rate of 4.4 percent, Finance Wire reports.

The surgery of spines has begun in the late 1800s. It was not systematic until around 1916 when the neurosurgeon Dr. Charles Elsberg published a book mentioning how to perform surgical procedures on the spine and spinal cord for various…